Principia BioPharma's IPO

Principia BioPharma raised a round of funding on September 14, 2018. Investors include Public.

Principia Biopharma is a biopharmaceutical company focused on discovering and developing small molecule drugs within the fields of autoimmune disease and oncology that are potent, safe and have antibo…

Articles about Principia BioPharma's IPO: